Chemerin and adiponectin contribute reciprocally to metabolic syndrome.

Obesity and metabolic syndrome (MetS) are considered chronic inflammatory states. Chemerin, a novel adipokine, may play an important role in linking MetS and inflammation. We investigated the association of chemerin with inflammatory markers and with characteristics of MetS in apparently healthy ove...

Full description

Bibliographic Details
Main Authors: Sang Hui Chu, Mi Kyung Lee, Ki Yong Ahn, Jee-Aee Im, Min Soo Park, Duk-Chul Lee, Justin Y Jeon, Ji Won Lee
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3324504?pdf=render
id doaj-1b20daccd9f346c58477c0f26b2dd728
record_format Article
spelling doaj-1b20daccd9f346c58477c0f26b2dd7282020-11-25T01:13:25ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0174e3471010.1371/journal.pone.0034710Chemerin and adiponectin contribute reciprocally to metabolic syndrome.Sang Hui ChuMi Kyung LeeKi Yong AhnJee-Aee ImMin Soo ParkDuk-Chul LeeJustin Y JeonJi Won LeeObesity and metabolic syndrome (MetS) are considered chronic inflammatory states. Chemerin, a novel adipokine, may play an important role in linking MetS and inflammation. We investigated the association of chemerin with inflammatory markers and with characteristics of MetS in apparently healthy overweight and obese adults. We studied 92 adults; 59 men and 33 women whose average body mass index (BMI) was 28.15 ± 5.08 kg/m(2). Anthropometric parameters, insulin resistance indices, lipid profiles, and inflammatory markers including high sensitivity C-reactive protein (hsCRP), pentraxin 3 (PTX3), adiponectin, and chemerin were measured. Controlling for age, gender, and BMI, serum chemerin level was positively correlated with body fat and serum triglyceride, and negatively correlated with adiponectin and high density lipoprotein cholesterol (HDL- C), and was not correlated with altered hsCRP or PTX3 levels. Among the low, moderate and high chemerin groups, high chemerin individuals are more likely to have lower HDL-C. Conversely, individuals in the low adiponectin group are more likely to have lower HDL-C and show more MetS phenotypic traits than moderate and high adiponectin subjects. To determine the relationships of chemerin and adiponectin to MetS and its components, participants were stratified into four groups based on their chemerin and adiponectin levels (high chemerin/high adiponectin, high chemerin/low adiponectin, low chemerin/high adiponectin, or low chemerin/low adiponectin). Participants who were in the high chemerin/low adiponectin group more likely to have dyslipidemia and MetS (OR: 5.79, 95% CI:1.00-33.70) compared to the other three group. Our findings suggest that chemerin and adiponectin may reciprocally participate in the development of MetS.http://europepmc.org/articles/PMC3324504?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Sang Hui Chu
Mi Kyung Lee
Ki Yong Ahn
Jee-Aee Im
Min Soo Park
Duk-Chul Lee
Justin Y Jeon
Ji Won Lee
spellingShingle Sang Hui Chu
Mi Kyung Lee
Ki Yong Ahn
Jee-Aee Im
Min Soo Park
Duk-Chul Lee
Justin Y Jeon
Ji Won Lee
Chemerin and adiponectin contribute reciprocally to metabolic syndrome.
PLoS ONE
author_facet Sang Hui Chu
Mi Kyung Lee
Ki Yong Ahn
Jee-Aee Im
Min Soo Park
Duk-Chul Lee
Justin Y Jeon
Ji Won Lee
author_sort Sang Hui Chu
title Chemerin and adiponectin contribute reciprocally to metabolic syndrome.
title_short Chemerin and adiponectin contribute reciprocally to metabolic syndrome.
title_full Chemerin and adiponectin contribute reciprocally to metabolic syndrome.
title_fullStr Chemerin and adiponectin contribute reciprocally to metabolic syndrome.
title_full_unstemmed Chemerin and adiponectin contribute reciprocally to metabolic syndrome.
title_sort chemerin and adiponectin contribute reciprocally to metabolic syndrome.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description Obesity and metabolic syndrome (MetS) are considered chronic inflammatory states. Chemerin, a novel adipokine, may play an important role in linking MetS and inflammation. We investigated the association of chemerin with inflammatory markers and with characteristics of MetS in apparently healthy overweight and obese adults. We studied 92 adults; 59 men and 33 women whose average body mass index (BMI) was 28.15 ± 5.08 kg/m(2). Anthropometric parameters, insulin resistance indices, lipid profiles, and inflammatory markers including high sensitivity C-reactive protein (hsCRP), pentraxin 3 (PTX3), adiponectin, and chemerin were measured. Controlling for age, gender, and BMI, serum chemerin level was positively correlated with body fat and serum triglyceride, and negatively correlated with adiponectin and high density lipoprotein cholesterol (HDL- C), and was not correlated with altered hsCRP or PTX3 levels. Among the low, moderate and high chemerin groups, high chemerin individuals are more likely to have lower HDL-C. Conversely, individuals in the low adiponectin group are more likely to have lower HDL-C and show more MetS phenotypic traits than moderate and high adiponectin subjects. To determine the relationships of chemerin and adiponectin to MetS and its components, participants were stratified into four groups based on their chemerin and adiponectin levels (high chemerin/high adiponectin, high chemerin/low adiponectin, low chemerin/high adiponectin, or low chemerin/low adiponectin). Participants who were in the high chemerin/low adiponectin group more likely to have dyslipidemia and MetS (OR: 5.79, 95% CI:1.00-33.70) compared to the other three group. Our findings suggest that chemerin and adiponectin may reciprocally participate in the development of MetS.
url http://europepmc.org/articles/PMC3324504?pdf=render
work_keys_str_mv AT sanghuichu chemerinandadiponectincontributereciprocallytometabolicsyndrome
AT mikyunglee chemerinandadiponectincontributereciprocallytometabolicsyndrome
AT kiyongahn chemerinandadiponectincontributereciprocallytometabolicsyndrome
AT jeeaeeim chemerinandadiponectincontributereciprocallytometabolicsyndrome
AT minsoopark chemerinandadiponectincontributereciprocallytometabolicsyndrome
AT dukchullee chemerinandadiponectincontributereciprocallytometabolicsyndrome
AT justinyjeon chemerinandadiponectincontributereciprocallytometabolicsyndrome
AT jiwonlee chemerinandadiponectincontributereciprocallytometabolicsyndrome
_version_ 1725162426003881984